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Abstract: Essential oils from Lavandula genus and the obtained hybrids are widely used for different
purposes such as perfume production in the cosmetic field and for its biological properties. This is
the first study on the liquid and vapour phase of Lavandula × intermedia “Grosso” essential oil grown
in the Lazio Region, Italy, investigated using headspace coupled to gas chromatography and mass
spectrometry (HS-GC/MS). The results showed the most abundant components were linalool and
linalyl acetate, followed by 1,8-cineole and terpinen-4-ol, while lavandulyl acetate and borneol were
identified as minor compounds, maintaining the same proportion in both the liquid and vapour
phase. Furthermore, we tested lavandin liquid and vapour phase essential oil on gram-negative
bacteria (Escherichia coli, Acinetobacter bohemicus, and Pseudomonas fluorescens) and gram-positive
bacteria (Bacillus cereus and Kocuria marina).
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1. Introduction
The genus Lavandula belongs to the Lamiaceae family, a medicinal aromatic plant family whose
essential oils (EOs) are widely used for applications in food, perfumery, and in the field of cosmetics;
it is also important for human health given its potential biological activities [1–6].
Lavandula species are found worldwide and consist of over 39 species, besides various intraspecific
taxa and hybrids, which differ in colour and period of flowering, foliage, and resistance to low
temperatures [7]. Lavandula angustifolia (also called L. officinalis or L. vera), Lavandula latifolia
(spike lavender), and Lavandula × intermedia Emeric ex Loisel (lavandin or lavandulil), a natural
sterile hybrid obtained by crossing L. angustifolia × L. latifolia are mainly used to produce EOs.
L. × intermedia is a shrub ranging from 60 to 150 cm, with linear-lanceolate to spathulate leaves,
which are often tomentose. Its inflorescence stalk is branched and flowers show a corolla with a
bilateral symmetry and are variable in colour from lilac-purple to white, blooming from late June
to July.
Lavandin is a much larger plant than the L. angustifolia varieties and is much appreciated for its
EO yield. This product is widely used all over the world by the fragrance industry and is a common
ingredient in soaps, laundry detergents, skin care, perfumes, and cleaning products.
L. × intermedia is present in Spain, France, and Italy with different cultivars among which is
L. × intermedia var. “Grosso”; it is characterised by dark violet-blue flowers and is the most widely
used for EO production [7].
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EOs, particularly abundant in aromatic plants, play a fundamental role in plant protection
against pathogens such as bacteria, fungi, and insects. Furthermore, they attract some insects to
allow the fertilization process by pollen and seed dispersion [8,9]. They are a hydrophobic complex
mixture of volatile compounds and are mainly composed of terpenes biogenerated by the mevalonate
pathway. These volatile molecules include monoterpenes (hydrocarbon and oxygenated monoterpens),
and sesquiterpenes (hydrocarbon and oxygenated sesquiterpens) [10]. They also contain phenolic
compounds derived from the shikimate pathway. Thanks to their chemical composition, EOs possess
antioxidant, anti-inflammatory, antimicrobial, antifungal, and anticancer properties [11–13].
Different biological activities were found in common lavender and lavandin EOs such as anxiolytic,
antioxidant, anti-inflammatory, antidepressant, analgesic, smooth-muscle relaxant, anti-parasitic,
anticancer, and apoptosis induction activity, as well as having beneficial immunomodulatory effects on
wound healing [14–21]. Moreover, it was reported that the EOs obtained from Lavandula are active on
many types of bacteria such as foodborne pathogens, human pathogenic bacteria, and environmental
bacteria [22–27]. Furthermore, Lavandula × intermedia and Lavandula Angustifolia essential oils, rich in
specific constituents such as linalool, camphor, and 1,8-cineole, possess antibacterial activities against
Listeria monocytogenes, especially against isolates from a clinical environment [28].
In the present study, we have analysed the chemical composition of the liquid and vapour phase
of L. × intermedia cv. “Grosso” essential oil (LEO) grown in the Lazio Region, Italy, investigated by
headspace coupled to gas chromatography and mass spectrometry (HS-GC/MS). We further studied
LEO’s antimicrobial properties against gram-negative bacteria (G−) (Escherichia coli, Acinetobacter
bohemicus, and Pseudomonas fluorescens) and gram-positive bacteria (G+) (Bacillus cereus and Kocuria
marina).
2. Results
2.1. LEO Chemical Composition
GC–MS analysis of the liquid phase showed the presence of 26 compounds (Table 1), of which
89.2% were monoterpenoids and 3.1% were sesquiterpenoids The most abundant components were
linalool (41.6%) and linalyl acetate (23.0%), followed by 1,8-cineole (5.2%) and terpinen-4-ol (4.8%).
Lavandulyl acetate (3.2%) and borneol (2.8%) were identified as minor compounds. Headspace GC–MS
analysis revealed different results. The percentages of the most volatile compounds increased while
that of the highest boiling compounds decreased as shown in Table 1. All the lower boiling compounds
showed a greater abundance. More specifically, α-pinene increased to 8.7% and 1,8-cineole reached
19.8%. In contrast, compounds eluted subsequently from the chromatographic column recorded a
decrease in their abundance compared to the analysis of the liquid phase. For example, linalool
decreased to 35.8%, linalyl acetate to 7.5%, and terpinen-4-ol to 2.9%.
Table 1. Chemical composition (%) of Lavandula × intermedia cv. “Grosso” essential oil (LEO).
No. Component 1 LRIlit 2 LRI 3 LRI 4
GC Peak
Area (%)
HS-GC Peak
Area (%)
1 α-pinene 1021 1019 935 1.1 8.7
2 camphene 1065 1055 946 0.5 3.7
3 β-pinene 1105 1100 981 0.4 2.8
4 myrcene 1156 1152 984 1.5 4.9
5 α-phellandrene 1160 1161 999 0.1 0.7
6 limonene 1198 1195 1025 1.0 3.5
7 1,8-cineole 1209 1210 1028 5.2 19.8
8 (Z)-β-ocimene 1237 1231 1038 0.9 -
9 γ-terpinene 1241 1235 1046 0.2 -
10 trans-β-ocimene 1276 1275 1055 0.7 -
11 terpinolene 1282 1283 1072 0.4 -
12 o-cymene 1287 1290 1025 0.2 1.7
Molecules 2019, 24, 2701 3 of 10
Table 1. Cont.
No. Component 1 LRIlit 2 LRI 3 LRI 4
GC Peak
Area (%)
HS-GC Peak
Area (%)
13 hexyl isobutyrate 1335 1333 1145 0.3 -
14 1-octen-3-yl-acetate 1401.9 1400 1122 0.5 0.7
15 hexyl butanoate 1410 1414 1177 0.5 -
16 1-octen-3-ol 1458 1461 970 0.3 0.4
17 camphor 1507 1500 1133 6.0 4.4
18 linalool 1537 1539 1092 41.6 35.8
19 linalyl acetate 1553 1549 1245 23.0 7.5
20 lavandulyl acetate 1584 1580 1265 3.2 0.8
21 terpinen-4-ol 1603 1600 1174 4.8 2.9
22 (E)-β-caryophyllene 1613 1615 1428 1.3 -
23 (Z)-β-farnesene 1630 1635 1445 1.3 -
24 α-terpineol 1675 1680 1185 1.6 0.4
25 γ-muurolene 1685 1687 1508 0.5 -
26 borneol 1717 1721 1158 2.8 1.2
Total (%) 99.9 99.9
Monoterpenoids 89.2 94.4
Sesquiterpenoids 3.1 -
Others 7.6 5.5
1 Elution order on polar column; 2 Linear retention indices from literature; 3 Linear retention indices measured on polar
column; 4 Linear retention indices measured on apolar column. HS-GC: Headspace coupled to gas chromatography.
Table 2 shows the qualitative aspects of LEO. The amounts of the components found were in line
with the levels accepted by the European Pharmacopeia (EPh). Only linalyl acetate was slightly below
the limits set by the EPh.
Table 2. Percentage of the main compounds in the LEO sample in comparison with the accepted
percentages by European Pharmacopoeia (EPh).
Component EPh Lavandin
linalool 25–45 41.6
linalyl acetate 25–46 23.0
1,8-cineole max. 2.5 5.2
camphor 12–18 6.0
2.2. LEO Antibacterial Activity—Agar Diffusion Method
The antibacterial activity of LEO was assessed according to the inhibition zone diameter (halo) and
the results obtained are summarised in Table 3. In the G− group, an inhibition halo of 8.5 ± 0.7 mm was
measured for P. fluorescens, while relative antibiotic control using gentamicin (gen) was 25.5 ± 0.7 mm;
E. coli showed an inhibition halo of 13 ± 1.41 mm (gen = 16.5 ± 2.12 mm) whereas A. bohemicus exhibited
a halo of 47 ± 4.24 mm (gen = 34.5 ± 0.7 mm). In the G+ group tested, the K. marina inhibition halo was
14.5 ± 2.12 mm (gen = 27 ± 2.83 mm) and that for B. cereus was 21.5 ± 0.7 mm (gen = 28.5 ± 0.7 mm).
2.3. Minimum Inhibitory Concentration (MIC)
The MIC represents the lowest concentration of antimicrobial agent that completely inhibits
growth. Values are reported in percentage of LEO (Table 4) revealing that the most resistant strain was
P. fluorescens (MICLEO = 3.75%, MICGEN = 1.56 µg/mL), followed by E. coli (MICLEO = 1.87%, MICGEN
= 3.12 µg/mL) and K. marina (MICLEO = 1.87%, MICGEN = 0.39 µg/mL), B. cereus (MICLEO = 0.94%,
MICGEN = 1.56 µg/mL), and A. bohemicus (MICLEO = 0.47%, MICGEN = 0.08 µg/mL). No bacterial
growth occurred in the sterility control, while regular growth was recorded in the negative control.
In all strains tested, DMSO antibacterial activity was not present for the MICLEO concentrations used.
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Table 3. Growth inhibition halo (mm) for LEO and the positive control (gentamicin) against the five
tested Gram+ and Gram− bacterial strains (p values ≤ 0.05).
Agar Diffusion Test LEO (10 µL) Gen (20 µg)
Strain halo ± SD (mm) halo ± SD (mm)
Gram−
Escherichia coli 13.0 ± 1.41 16.5 ± 2.12
Acinetobacter bohemicus 47.0 ± 4.24 34.5 ± 0.70
Pseudomonas fluorescens 8.5 ± 0.70 25.5 ± 0.70
Gram+
Bacillus cereus 21.5 ± 0.70 28.5 ± 0.70
Kocuria marina 14.5 ± 2.12 27.0 ± 2.83
Table 4. Minimum inhibitory concentration (MIC) and Minimum bactericidal concentration (MBC)
means for LEO expressed in percentage values (%) and the positive control (gentamicin) expressed in
µg/mL against the five tested bacterial strains.
Microdilution Test LEO Gen
Strain MIC(%Mean)
MBC
(%Mean)
MIC
(µg/mLMean)
MBC
(µg/mLMean)
Gram−
E. coli 1.87 1.87 3.12 6.25
A. bohemicus 0.47 0.47 0.08 0.31
P. fluorescens 3.75 7.51 1.56 6.25
Gram+
B. cereus 0.94 Bacteriostatic 1.56 3.12
K. marina 1.87 Bacteriostatic 0.39 1.56
2.4. Minimum Bactericidal Concentration (MBC)
MBC is expressed as the lowest concentration of essential oil where no visible growth on agar
occurred. LEO tested on the G+ group displayed a bacteriostatic effect, while on the G− group it
recorded results that were consistent with the MIC data recorded before: P. fluorescens showed an MBC
of 7.50%, E. coli was 1.87%, and A. bohemicus was 0.47%; higher values of both MIC and MBC were
obtained by using gen as a positive control (Table 4).
2.5. Vapour Phase Test (VPT)
The VPT used to evaluate the antimicrobial activity of the LEO vapour phase is shown in Table 5.
After 24 h of incubation time, differing results emerged: For P. fluorescens, the MIC was higher than
40 µL whereas K. marina, E. coli, and B. cereus recorded an MIC of 20 µL. A. bohemicus recorded the
lowest level, with an MIC of 2 µL. After seven days the plates were checked to evaluate the bactericidal
and bacteriostatic activity. No differences were found in B. cereus and P. fluorescens compared with the
previous check, recording an MBC of 20 µL and more than 40 µL, respectively; moreover in E. coli and
K. marina, colonies were found in the 2 and 20 µL treatments while MBC was 40 µL. In A. bohemicus,
the MBC was 20 µL.
Molecules 2019, 24, 2701 5 of 10
Table 5. LEO vapour phase test showing minimum inhibitory concentration (MIC) and minimum
bactericidal concentration means (MBC) expressed in µL against the five bacteria tested.
LEO VPT (Vapour Phase Test)
Strain MIC (µL Mean) * MBC (µL Mean)
Gram−
E. coli 20 40
A. bohemicus <2 20
P. fluorescens >40 >40
Gram+
B. cereus 20 20
K. marina 20 40
* After seven days.
3. Discussion
LEO liquid and vapour phases were investigated by HS-GC/MS analysis and the presence of
monoterpenoids and sesquiterpenoids were highlighted. The most abundant components were linalool
and linalyl acetate followed by eucalyptol and terpinen-4-ol, while lavandulyl acetate and borneol were
identified as minor compounds. These molecules are mainly responsible for lavandin’s characteristic
flavour and for their biological and therapeutic properties [29]. Depending on the different types of
lavandin, variations in the chemical composition were found. Ghelardini et al. (1999) [30] described
the chemical composition of L. angustifolia essential oil of Italian origin, characterised by linalool
(31.5%), linalyl acetate (43.0%), and β-caryophyllene (5.0%) as the main compounds. Caputo et al.
(2016) [31] analysed L. angustifolia essential oil obtained from the hydrodistillation of the plant grown
in Salerno (Campania, Italy) and showed a composition rich in linalool (33.1%) and linalyl acetate
(10.4%) and with low percentages of minor compounds. Iranian lavandin was characterised by
1,8-cineole (47.9%) as its main component followed by borneol (26.4%) and camphor (14.4%) [32]
(Bajalan et al. 2017), while Romanian lavandin essential oil was richer in camphor and 1,8-cineole [33].
The essential lavender oil grown in India consisted of linalool (28.06%) and linalyl acetate (47.5%) [34].
The major compounds of a Lavandula hybrid grown in Northern Italy were linalyl acetate and borneol,
which together accounted for 70% [35]. In our study, the sum of these two compounds did not
exceed 25.8% and LEO revealed a high content of linalool (41.6%), while linalyl acetate reached 23.0%;
1,8-cineole (5.2%) and camphor (6.0%) were present as secondary compounds. A previous study
carried out on the same type of lavandin grown in Tuscany, Italy, [36] reported that linalyl acetate
amounted to 14.7%, 1,8-cineole 7.8%, and camphor 7.7%. All these variations in the percentages of the
compounds detected could be either due to the cultivation area’s altitude or its microclimate. As for
the quality of the LEO obtained, the component amounts found were in line with the levels accepted
by the European Pharmacopeia (EPh) (Table 2). Only linalyl acetate was slightly below the limits set
by EPh.
The results obtained from the different tests on bacteria showed that A. bohemicus was the more
sensitive strain to LEO with an inhibition halo of 47 mm and an MIC of 0.47% in the broth microdilution
test, followed by B. cereus with a halo of 21.5 mm and an MIC of 0.94%. E. coli and K. marina
showed similar values, both as regards the disk diffusion test (13.0 and 14.5 mm, respectively) and
the microdilution test (both 1.87%). P. fluorescens proved to be the most resistant of all bacteria tested
with an inhibition halo of 8.5 mm and an MIC of 3.75%. As seen in Table 4, the MBC values showed
bactericidal activity of LEO at the MIC concentration for A. bohemicus and E. coli, while for P. fluorescens
the MIC increased to 7.5%. This bactericidal effect occurred only for the G− bacteria, while for the G+
bacteria bacteriostatic effects were observed, contributing to the formation of colonies after inhibition
agent removal (results of the agar diffusion test are shown in Figure 1). Furthermore, in the VPT,
A. bohemicus proved the most sensitive to LEO treatments with an MIC lower than the minimum
concentration used for the test; B. cereus, E. coli, and K. marina recorded an identical MIC, varying
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slightly from the data previously obtained in the liquid phase. P. fluorescens achieved an MIC higher
than the maximum concentration tested, 40 µL.Molecules 2019, 24, x 6 of 10 
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4. Materials and Methods
4.1. Plant Materials
The LEO (IT BIO 007 D86K, lot number MGL01/18) was directly provided by the agricultural
enterprise, Azienda Agricola Podere dell’Arco (Viterbo, Lazio), as a steam-distilled sample obtained
from a cultivar of lavandin (L. × intermedia “Grosso”).
4.2. Gas Chromatography–Mass Spectrometry (GC–MS) Analysis
The essential oil was analysed by gas chromatograph directly coupled to a mass spectrometer
(MS) Perkin Elmer Inc., Clarus 500 model (Waltham, MA, USA). The GC was equipped with two
columns, one of which was a Restek Stabilwax (fused-silica) polar capillary column, and the other
was a Varian (VF-1ms) apolar column. Helium was used as carrier gas at a flow rate of 1 mL/min [37].
The Restek column was operated using an injector temperature of 280 ◦C and the following oven
temperature program: Isothermal at 60 ◦C for 5 min, then ramped to 220 ◦C at a rate of 5 ◦C min−1,
and finally isothermal at 220 ◦C for 20 min. The other apolar column was operated using an injector
temperature of 280 ◦C and the following oven temperature program: Isothermal at 60 ◦C for 5 min,
then ramped to 220 ◦C at a rate of 5 ◦C min−1, a second ramp to 260 ◦C at a rate of 5 ◦C min−1 and
finally isothermal at 260 ◦C for 10 min. One microlitre of lavandin EO was diluted in 1 mL of methanol
and the injection volume was 1 µL. The injector split ratio was 1:20. Mass spectra were recorded at
70 eV (EI: electronic impact) and were scanned in the range 40–400 m/z. The GC-TIC (total ion current)
mass spectra were obtained by data analysis software (TurboMassTM GC/ MS PerkinElmer). The LEO
constituents were identified by comparison of their linear retention indices (LRIs), (relative to C8–C30
aliphatic hydrocarbons, Ultrasci injected into both polar and apolar columns under the same operating
conditions described above) with available retention data in the literature. Further identification of all
components was made by matching their mass spectra with those stored in the Wiley and NIST02
mass spectra libraries database. GC-FID (flame-ionization detector) analysis was performed under
the same experimental conditions using the polar column as described for the GC–MS measurements.
The FID temperature was 280 ◦C. Relative amounts of the essential oil components were obtained by
peak area normalisation without the use of an internal standard or correction factors and expressed in
percentages. All analyses were repeated twice.
4.3. Headspace GC–MS Analysis
The volatile constituents were analysed by a PerkinElmer Inc., Headspace Turbomatrix
40 autosampler coupled to GC and GC–MS (Waltham, MA, USA). [38,39]. The procedures were
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optimised. The gas phase of the sealed vials was equilibrated for 20 min at 60 ◦C and was followed
immediately by compound desorption into the GC injector in splitless mode. Quantification of
compounds was performed by GC-FID under the same conditions described above.
4.4. Microorganisms Tested and Growth Conditions
Bacterial strains were obtained from the culture collections of Plant Cytology and Biotechnology
Laboratory of Tuscia University and the Institute of Pharmacy and Molecular Biotechnology at
Heidelberg University. Five microbial cultures belonging to gram-positive (G+) and gram-negative
(G−) bacteria were tested: E. coli American Type Culture Collection-ATCC 25,922 (G−), B. cereus ATCC
10,876 (G+), A. bohemicus DSM 102,855 (G−), K. marina DSM 16,420 (G+), and P. fluorescens ATCC
13,525 (G−).
All tested bacterial strains were maintained on Lysogeny Broth agar (LB agar preparation: 10 g
tryptone, 5 g yeast extract, 10 g NaCl, and 15 g agar per litre, autoclaved at 121 ◦C for 20 min) at
different temperatures: 26 ◦C for B. cereus, P. fluorescens, and A. bohemicus, and 37 ◦C for K. marina and
E. coli. All inocula were prepared with fresh cultures plated the day before the test.
4.5. Agar Diffusion Method
Fresh bacterial strains were suspended in Lysogeny Broth (LB preparation: 10 g tryptone, 5 g
yeast extract, 10 g NaCl per litre, autoclaved at 121 ◦C for 20 min) to obtain a turbidity of 0.5 McFarland
(approximately 108 Colony Forming Unit/mL—CFU/mL) and then seeded on LB agar. Sterile disks
(6 mm diameter) were placed on the agar and impregnated with 10 µL of pure LEO. As a positive
control, 2 µL of gentamicin from a stock solution (10 mg/mL) was used.
The inhibitory activity was recorded as mm of halo diameter without growth around the disks [40].
Each bacterial strain was tested in duplicate and the halo of the inhibition zones measured using a
vernier caliper rule. The average and the respective standard deviation (SD) of the three replicates
were recorded.
4.6. Minimum Inhibitory Concentration (MIC)
The MIC is the lowest concentration of antimicrobial agent that completely inhibits growth of the
organism in microdilution wells as detected by the unaided eye [40]. MIC values were determined
according to the microwell dilution method [41], with small adjustments. Briefly, 96-microplate wells
were prepared by adding 12 dilutions of LEO in Lysogeny broth, from 7.5% to 0.0037%, a growth
control without treatments, a control with the same percentage (from 5% to 0.002%) of dimethyl
sulfoxide (DMSO) used to solubilise LEO in an aqueous medium, a positive control with gentamicin
diluted from 100 to 0.049 µg, and a sterility control without bacteria. In all wells, except for the sterility
control, 50 µL of inoculum, previously diluted from 108 to 106 CFU/mL, were added and the plates
were incubated for 20 h. To better visualise the inhibition activity, 20 µL of a solution 200 µg/mL
of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were added. The assay was
carried out in triplicate.
4.7. Minimum Bactericidal Concentration (MBC)
Before adding MTT to display the effective bacteria growth, 10 µL of the last four dilutions with
no presence of turbidity were plated in an agarised Petri plate with LB agar and incubated for 24 h.
The MBC was evaluated as the lowest concentration where no growth on agar occurred. The assay
was carried out in triplicate.
4.8. Vapour Phase Test (VPT)
The antibacterial activity of LEO vapour phase was evaluated by the modified disk volatisation
methods [42–44]. Briefly, 15 mL of liquid LB agar were poured into a 90 mm plastic Petri dish and 5
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mL into its cover to prevent interactions between the plastic and LEO. After solidification, the fresh
bacterial suspension containing 108 CFU/mL was inoculated in the medium. Different aliquots of
LEO were put in a 6 mm sterile disk: 40, 20, and 2 µL. A negative control was prepared with a plate
without LEO. Liquid LB agar was put in the space between the cover and the base of the Petri dishes
to facilitate the sealing. During the solidification time, the Petri dishes were sealed with the aid of
an adhesive tape to hold the edges of the plate with its respective counterpart to prevent any LEO
leakage. The dishes were put into a plastic bag and incubated for 24 h. After the incubation time,
the presence or absence of microbes was visually evaluated and the plates were checked after seven
days to investigate the bactericidal or bacteriostatic activity. All VPTs were carried out in triplicate.
4.9. Statistical Analysis
The results were expressed as means ± standard deviation (SD). Data were analysed with one-way
analysis of variance (ANOVA) using GraphPad Prism software (GraphPad Prism 5.0, GraphPad
Software, Inc., San Diego, CA, USA), with p values ≤ 0.05 as statistically significant.
5. Conclusions
This work aimed to chemically characterise the vapour and liquid phase of L. × intermedia “Grosso”
essential oil (LEO).
Its main components were linalool and linalyl acetate followed by 1,8-cineole and terpinen-4-ol.
Antimicrobial activity was also tested and the results showed a bactericidal effect on G− bacteria and
a bacteriostatic effect on G+ bacteria with an overlapping trend for the vapour and liquid phases.
Lavandin, a natural sterile hybrid obtained by crossing L. angustifolia × L. latifolia and grown in the
Lazio Region, Italy, was characterised for the first time in this work. Future studies will occur to test
the single or combined activity of the main constituents and their possible uses in cosmetic, food,
and pharmaceutical fields
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